COSOPT Preservative-Free 20 mg/ml + 5 mg/ml eye drops, solution

Kraj: Wielka Brytania

Język: angielski

Źródło: myHealthbox

Kup teraz

Pobierz Ulotka dla pacjenta (PIL)
03-06-2024

Składnik aktywny:

dorzolamide hydrochloride

Dostępny od:

Santen Oy

Kod ATC:

Santen Oy

INN (International Nazwa):

dorzolamide hydrochloride

Dawkowanie:

22.26 mg

Forma farmaceutyczna:

Eye drops, solution, single dose container

Droga podania:

ocular route

Sztuk w opakowaniu:

30 x 0.2 ml, 60 x 0.2 ml, 120 x 0.2 ml

Typ recepty:

POM - Prescription Only Medicine

Wyprodukowano przez:

Santen Oy

Grupa terapeutyczna:

Antiglaucoma preparations and miotics, Beta blocking agents, Timolol, combinations

Wskazania:

Indicated in the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.

Status autoryzacji:

Authorised

Data autoryzacji:

2015-08-01

Ulotka dla pacjenta

                                EU INSERT 01-30-2013 
2  
220413
160.37x628.65
Black
Technical Info
STW-SA60100
050315-2
SA60100
461817A02
Profile
PACKAGE LEAFLET: INFORMATION FOR THE USER
COSOPT® PRESERVATIVE-FREE 20 MG/ML + 5 MG/ML 
EYE DROPS, SOLUTION, SINGLE DOSE CONTAINER
(dorzolamide / timolol)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS 
IMPORTANT INFORMATION FOR YOU.
-  Keep this leaflet. You may need to read it again.
-  If you have any further questions, ask your doctor or pharmacist.
-  This medicine has been prescribed for you only. Do not pass it on
to others. It may harm 
them, even if their signs of illness are the same as yours.
-  
If you get any side effects, talk to your doctor or pharmacist. This
includes any side effects 
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.  What COSOPT Preservative-Free is and what it is used for
2.  What you need to know before you use COSOPT Preservative-Free
3.  How to use COSOPT Preservative-Free
4.  Possible side effects
5.  How to store COSOPT Preservative-Free
6.  Contents of the pack and other information
1.  WHAT COSOPT PRESERVATIVE-FREE IS AND WHAT IT IS USED FOR
COSOPT Preservative-Free contains two medicines: dorzolamide and
timolol.
•  Dorzolamide belongs to a group of medicines called “carbonic
anhydrase inhibitors”.
•  Timolol belongs to a group of medicines
called “beta-blockers.”
These medicines lower pressure in the eye in different ways.
COSOPT Preservative-Free is prescribed to lower raised pressure in the
eye in the treatment of glaucoma when 
beta-blocker eyedrop medicine used alone is not adequate.
2.  WHAT YOU NEED TO KNOW BEFORE YOU USE COSOPT PRESERVATIVE-FREE
DO NOT USE COSOPT PRESERVATIVE-FREE
•  if you are allergic to dorzolamide hydrochloride, timolol
maleate or any of the other ingredients of this 
medicine (listed in section 6).
•  if you have now or had in the past respiratory problems, such
as asthma or severe chronic obstructive
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                &262373UHVHUYDWLYH)UHHPJPOPJPOH\HGURSVVROXWLRQ
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_6DQWHQ8./LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
&26237
Š
3UHVHUYDWLYH)UHHPJPOPJPOH\HGURSVVROXWLRQ
VLQJOHGRVHFRQWDLQHU
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKPOFRQWDLQVPJRIGRU]RODPLGHK\GURFKORULGHFRUUHVSRQGLQJWRPJGRU]RODPLGHDQGPJRIWLPRORO
PDOHDWHFRUUHVSRQGLQJWRPJWLPRORO
)RUWKHIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
(\HGURSVVROXWLRQVLQJOHGRVHFRQWDLQHU
&OHDUFRORXUOHVVWRQHDUO\FRORXUOHVVVOLJKWO\YLVFRXVVROXWLRQZLWKDS+EHWZHHQDQGDQGDQRVPRODULW\RI
P2V0
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
,QGLFDWHGLQWKHWUHDWPHQWRIHOHYDWHGLQWUDRFXODUSUHVVXUH,23LQSDWLHQWVZLWKRSHQDQJOHJODXFRPDRU
SVHXGRH[IROLDWLYHJODXFRPDZKHQWRSLFDOEHWDEORFNHUPRQRWKHUDS\LVQRWVXIILFLHQW
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
3RVRORJ\
7KHGRVHLVRQHGURSRI&262373UHVHUYDWLYH)UHHLQWKHFRQMXQFWLYDOVDFRIWKHDIIHFWHGH\HVWZRWLPHVGDLO\
,IDQRWKHUWRSLFDORSKWKDOPLFDJHQWLVEHLQJXVHG&262373UHVHUYDWLYH)UHHDQGWKHRWKHUDJHQWVKRXOGEH
DGPLQLVWHUHGDWOHDVWWHQPLQXWHVDSDUW
7KLVPHGLFLQDOSURGXFWLVDVWHULOHVROXWLRQWKDWGRHVQRWFRQWDLQDSUHVHUYDWLYH7KHVROXWLRQIURPRQHLQGLYLGXDOVLQJOH
GRVHFRQWDLQHULVWREHXVHGLPPHGLDWHO\DIWHURSHQLQJIRUDGPLQLVWUDWLRQWRWKHDIIHFWHGH\HV6LQFHVWHULOLW\FDQQRW
EHPDLQWDLQHGDIWHUWKHLQGLYLGXDOVLQJOHGRVHFRQWDLQHULVRSHQHGDQ\UHPDLQLQJFRQWHQWVPXVWEHGLVFDUGHG
LPPHGLDWHO\DIWHUDGPLQLVWUDWLRQ
3DWLHQWVVKRXOGEHLQVWUXFWHGWRZDVKWKHLUKDQGVEHIRUHXVHDQGDYRLGDOORZLQJWKHFRQWDLQHUWRFRPHLQWRFRQWDFWZLWK
WKHH\HRUVXUURXQGLQJVWUXFWXUHVDVWKLVFRXOGFDXVHLQMXU\WRWKHH\HVHHLQVWUXFWLRQVIRUXVH
3DWLHQWVVKRXOGDOVREHLQVWUXFWHGWKDWRFXODUVROXWLRQVLIKDQGOHGLPSURSHUO\FDQEHFRPHFRQWDPLQDWHGE\FRPPRQ
EDFWHULDNQRZQWRFDXVHRFXODULQIHFWLRQV6HULRXVGDPDJHWRW
                                
                                Przeczytaj cały dokument